A siRNA targets and inhibits a broad range of SARS‐CoV‐2 infections including Delta variant

The emergence of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) variants has altered the trajectory of the COVID‐19 pandemic and raised some uncertainty on the long‐term efficiency of vaccine strategy. The development of new therapeutics against a wide range of SARS‐CoV‐2 variants is i...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Yi‐Chung, Yang, Chi‐Fan, Chen, Yi‐Fen, Yang, Chia‐Chun, Chou, Yuan‐Lin, Chou, Hung‐Wen, Chang, Tein‐Yao, Chao, Tai‐Ling, Hsu, Shu‐Chen, Ieong, Si‐Man, Tsai, Ya‐Min, Liu, Ping‐Cheng, Chin, Yuan‐Fan, Fang, Jun‐Tung, Kao, Han‐Chieh, Lu, Hsuan‐Ying, Chang, Jia‐Yu, Weng, Ren‐Shiuan, Tu, Qian‐Wen, Chang, Fang‐Yu, Huang, Kuo‐Yen, Lee, Tong‐Young, Chang, Sui‐Yuan, Yang, Pan‐Chyr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988202/
https://www.ncbi.nlm.nih.gov/pubmed/35138028
http://dx.doi.org/10.15252/emmm.202115298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988202/
https://www.ncbi.nlm.nih.gov/pubmed/35138028
http://dx.doi.org/10.15252/emmm.202115298

Ejemplares similares